Distinct color changes (Figure 6e) and spectral shifts in the plasmon band (Figure 6f) were observed in the LS-AuNPs treated with the tumor lysates of MDA-MB-231 tumors in comparison with the MCF-7 or MDA-MB-231 tumors treated with LOX inhibitors. Here, LOX is linked to neoplasm.